Chapter 1 Industry Overview 1.1 Definition 1.2 Brief Introduction of Major Classifications 1.2.1 Autologous Stem Cell 1.2.2 Non-Stem Cell 1.2.3 1.2.4 1.2.5 1.3 Brief Introduction of Major Applications 1.3.1 Medical Centers and Universities 1.3.2 Clinical Laboratories 1.3.3 1.3.4 1.3.5 1.4 Brief Introduction of Major Regions 1.4.1 United States 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 India Chapter 2 Production Market Analysis 2.1 Global Production Market Analysis 2.1.1 2012-2017 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 2.1.2 2012-2017 Major Manufacturers Performance and Market Share 2.2 Regional Production Market Analysis 2.2.1 2012-2017 Regional Market Performance and Market Share 2.2.2 United States Market 2.2.3 Europe Market 2.2.4 China Market 2.2.5 Japan Market 2.2.6 India Market 2.2.7 Market Chapter 3 Sales Market Analysis 3.1 Global Sales Market Analysis 3.1.1 2012-2017 Global Sales Volume, Sales Price and Sales Revenue Analysis 3.1.2 2012-2017 Major Manufacturers Performance and Market Share 3.2 Regional Sales Market Analysis 3.2.1 2012-2017 Regional Market Performance and Market Share 3.2.2 United States Market 3.2.3 Europe Market 3.2.4 China Market 3.2.5 Japan Market 3.2.6 India Market 3.2.7 Market Chapter 4 Consumption Market Analysis 4.1 Global Consumption Market Analysis 4.1.1 2012-2017 Global Consumption Volume Analysis 4.2 Regional Consumption Market Analysis 4.2.1 2012-2017 Regional Market Performance and Market Share 4.2.2 United States Market 4.2.3 Europe Market 4.2.4 China Market 4.2.5 Japan Market 4.2.6 India Market 4.2.7 Market Chapter 5 Production, Sales and Consumption Market Comparison Analysis 5.1 Global Production, Sales and Consumption Market Comparison Analysis 5.2 Regional Production, Sales Volume and Consumption Volume Market Comparison Analysis 5.2.1 United States 5.2.2 Europe 5.2.3 China 5.2.4 Japan 5.2.5 India 5.2.6 Chapter 6 Major Manufacturers Production and Sales Market Comparison Analysis 6.1 Global Major Manufacturers Production and Sales Market Comparison Analysis 6.1.1 2012-2017 Global Major Manufacturers Production and Sales Market Comparison 6.2 Regional Major Manufacturers Production and Sales Market Comparison Analysis 6.2.1 United States 6.2.2 Europe 6.2.3 China 6.2.4 Japan 6.2.5 India 6.2.6 Chapter 7 Major Classification Analysis 7.1 2012-2017 Major Classification Market Share 7.2 Autologous Stem Cell 7.3 Non-Stem Cell 7.4 7.5 7.6 Chapter 8 Major Application Analysis 8.1 2012-2017 Major Application Market Share 8.2 Medical Centers and Universities 8.2.1 2012-2017 Consumption Analysis 8.2.2 Major Down Stream Customers Analysis 8.3 Clinical Laboratories 8.3.1 2012-2017 Consumption Analysis 8.3.2 Major Down Stream Customers Analysis 8.4 8.4.1 2012-2017 Consumption Analysis 8.4.2 Major Down Stream Customers Analysis 8.5 8.5.1 2012-2017 Consumption Analysis 8.5.2 Major Down Stream Customers Analysis 8.6Global 8.6.1 2012-2017 Consumption Analysis 8.6.2 Major Down Stream Customers Analysis Chapter 9 Industry Chain Analysis 9.1 Up Stream Industries Analysis 9.1.1 Raw Material and Suppliers 9.1.2 Equipment and Suppliers 9.2 Manufacturing Analysis 9.2.1 Manufacturing Process 9.2.2 Manufacturing Cost Structure 9.2.3 Manufacturing Plants Distribution Analysis 9.3 Industry Chain Structure Analysis Chapter 10 Global and Regional Market Forecast 10.1 Production Market Forecast 10.1.1 Global Market Forecast 10.1.2 Major Region Forecast 10.2 Sales Market Forecast 10.2.1 Global Market Forecast 10.2.2 Major Classification Forecast 10.3 Consumption Market Forecast 10.3.1 Global Market Forecast 10.3.2 Major Region Forecast 10.3.3 Major Application Forecast Chapter 11 Major Manufacturers Analysis 11.1 ANTRIA (CRO) (U.S.) 11.1.1 Company Introduction 11.1.2 Product Specification and Major Types Analysis 11.1.3 2012-2017 Production Market Performance 11.1.4 2012-2017 Sales Market Performance 11.1.5 Contact Information 11.2 BIOHEART (U.S.) 11.2.1 Company Introduction 11.2.2 Product Specification and Major Types Analysis 11.2.3 2012-2017 Production Market Performance 11.2.4 2012-2017 Sales Market Performance 11.2.5 Contact Information 11.3 BRAINSTORM CELL THERAPEUTICS (U.S.) 11.3.1 Company Introduction 11.3.2 Product Specification and Major Types Analysis 11.3.3 2012-2017 Production Market Performance 11.3.4 2012-2017 Sales Market Performance 11.3.5 Contact Information 11.4 CYTORI (U.S.) 11.4.1 Company Introduction 11.4.2 Product Specification and Major Types Analysis 11.4.3 2012-2017 Production Market Performance 11.4.4 2012-2017 Sales Market Performance 11.4.5 Contact Information 11.5 DENDREON CORPORATION (U.S.) 11.5.1 Company Introduction 11.5.2 Product Specification and Major Types Analysis 11.5.3 2012-2017 Production Market Performance 11.5.4 2012-2017 Sales Market Performance 11.5.5 Contact Information 11.6 FIBROCELL (U.S.) 11.6.1 Company Introduction 11.6.2 Product Specification and Major Types Analysis 11.6.3 2012-2017 Production Market Performance 11.6.4 2012-2017 Sales Market Performance 11.6.5 Contact Information 11.7 GENESIS BIOPHARMA (U.S.) 11.7.1 Company Introduction 11.7.2 Product Specification and Major Types Analysis 11.7.3 2012-2017 Production Market Performance 11.7.4 2012-2017 Sales Market Performance 11.7.5 Contact Information 11.8 GEORGIA HEALTH SCIENCES UNIVERSITY (U.S.) 11.8.1 Company Introduction 11.8.2 Product Specification and Major Types Analysis 11.8.3 2012-2017 Production Market Performance 11.8.4 2012-2017 Sales Market Performance 11.8.5 Contact Information 11.9 NEOSTEM (U.S.) 11.9.1 Company Introduction 11.9.2 Product Specification and Major Types Analysis 11.9.3 2012-2017 Production Market Performance 11.9.4 2012-2017 Sales Market Performance 11.9.5 Contact Information 11.10 OPEXA THERAPEUTICS (U.S.) 11.10.1 Company Introduction 11.10.2 Product Specification and Major Types Analysis 11.10.3 2012-2017 Production Market Performance 11.10.4 2012-2017 Sales Market Performance 11.10.5 Contact Information 11.11 ORGENESIS (U.S.) 11.11.1 Company Introduction 11.11.2 Product Specification and Major Types Analysis 11.11.3 2012-2017 Production Market Performance 11.11.4 2012-2017 Sales Market Performance 11.11.5 Contact Information 11.12 REGENEXX (U.S.) 11.12.1 Company Introduction 11.12.2 Product Specification and Major Types Analysis 11.12.3 2012-2017 Production Market Performance 11.12.4 2012-2017 Sales Market Performance 11.12.5 Contact Information 11.13 REGENEUS (AUSTRALIA) 11.13.1 Company Introduction 11.13.2 Product Specification and Major Types Analysis 11.13.3 2012-2017 Production Market Performance 11.13.4 2012-2017 Sales Market Performance 11.13.5 Contact Information 11.14 TENGION (U.S.) 11.14.1 Company Introduction 11.14.2 Product Specification and Major Types Analysis 11.14.3 2012-2017 Production Market Performance 11.14.4 2012-2017 Sales Market Performance 11.14.5 Contact Information 11.15 TIGENIX (BELGIUM) 11.15.1 Company Introduction 11.15.2 Product Specification and Major Types Analysis 11.15.3 2012-2017 Production Market Performance 11.15.4 2012-2017 Sales Market Performance 11.15.5 Contact Information 11.16 VIRXSYS (U.S.) 11.16.1 Company Introduction 11.16.2 Product Specification and Major Types Analysis 11.16.3 2012-2017 Production Market Performance 11.16.4 2012-2017 Sales Market Performance 11.16.5 Contact Information 11.17 11.17.1 Company Introduction 11.17.2 Product Specification and Major Types Analysis 11.17.3 2012-2017 Production Market Performance 11.17.4 2012-2017 Sales Market Performance 11.17.5 Contact Information 11.18 11.18.1 Company Introduction 11.18.2 Product Specification and Major Types Analysis 11.18.3 2012-2017 Production Market Performance 11.18.4 2012-2017 Sales Market Performance 11.18.5 Contact Information 11.19 11.19.1 Company Introduction 11.19.2 Product Specification and Major Types Analysis 11.19.3 2012-2017 Production Market Performance 11.19.4 2012-2017 Sales Market Performance 11.19.5 Contact Information 11.20 11.20.1 Company Introduction 11.20.2 Product Specification and Major Types Analysis 11.20.3 2012-2017 Production Market Performance 11.20.4 2012-2017 Sales Market Performance 11.20.5 Contact Information Chapter 12 New Project Investment Feasibility Analysis 12.1 New Project SWOT Analysis 12.2 New Project Investment Feasibility Analysis Chapter 13 Conclusions Chapter 14 Appendix Author List Disclosure Section Research Methodology Data Source Interview List Global Disclaimer